Characterizing sudden death and dead-in-bed syndrome in Type 1 diabetes: analysis from two childhood-onset Type 1

A M Secrest1, D J Becker, S F Kelsey

  • 1Department of Epidemiology, University of Pittsburgh, Pittsburgh, PA, USA.

Insights

Sudden unexplained death in Type 1 diabetes is 10-fold higher, particularly in males. Dead-in-bed syndrome is linked to high HbA1c and insulin dose, suggesting metabolic factors contribute to these tragic events.

Area of Science:

  • Endocrinology
  • Epidemiology
  • Pediatric Medicine

Background:

  • Type 1 diabetes mellitus (T1DM) is associated with an increased risk of sudden unexplained death.
  • The 'dead-in-bed' (DIB) syndrome describes sudden, unwitnessed deaths in young, healthy individuals with diabetes.
  • Understanding the factors contributing to these deaths is crucial for prevention and improved patient outcomes.

Purpose of the Study:

  • To investigate the incidence and causes of sudden unexplained death and DIB syndrome in individuals with childhood-onset T1DM.
  • To identify potential risk factors, including metabolic and demographic characteristics, associated with these adverse events.

Main Methods:

  • A retrospective cohort study identified 1319 individuals with childhood-onset T1DM from two registries (1965-1979).
  • Causes of death were determined by a Mortality Classification Committee (MCC) using death certificates and additional records.
  • Analysis focused on unwitnessed deaths, specifically those meeting DIB criteria.

Main Results:

  • Of 255 reviewed deaths, 19 (8%) were sudden unexplained deaths and 7 met DIB criteria.
  • Causes of DIB deaths included diabetic coma (n=4), unknown (n=2), and cardiomyopathy (n=1).
  • Individuals with DIB had higher HbA1c, lower BMI, and higher insulin doses compared to controls.

Conclusions:

  • Sudden unexplained death appears to be approximately 10-fold higher in T1DM, with a notable association with male sex.
  • DIB deaths in T1DM are associated with poor glycemic control (high HbA1c), higher insulin requirements, and low body mass index (BMI).
  • These findings suggest that specific sex and metabolic factors may predispose individuals to sudden unexplained and DIB deaths in T1DM, though larger studies are needed.
Abstract

Related Concept Videos

Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Diabetic Ketoacidosis l: Introduction01:25

Diabetic Ketoacidosis l: Introduction

DefinitionDiabetic ketoacidosis (DKA) is an acute, life-threatening complication of diabetes mellitus, characterized by a triad of hyperglycemia (blood glucose >250 mg/dL), ketonemia or ketonuria, and metabolic acidosis (arterial pH <7.30 and serum bicarbonate <18 mEq/L). It results from insulin deficiency combined with elevated levels of counterregulatory hormones—glucagon, catecholamines, cortisol, and growth hormone—leading to increased lipolysis, hepatic ketone production, and...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...